Fiona Lawrence
Conseiller Juridique Général chez ARECOR THERAPEUTICS PLC
Fortune : 145 756 $ au 31/05/2024
Provenance du réseau au premier degré de Fiona Lawrence
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Fiona Lawrence via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MONSANTO | Wholesale Distributors | Corporate Officer/Principal | |
Insense Ltd.
 Insense Ltd. BiotechnologyHealth Technology Insense Ltd. develops products for treatment of wounds and skin conditions. Its development activity is concentrated on dermatology products for both professional and consumer applications. The company was founded in 2001 by Paul James Davis and is headquartered in Bedford, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
Piper Sandler Ltd.
 Piper Sandler Ltd. Investment Banks/BrokersFinance Part of Piper Sandler Cos., Piper Sandler Ltd. is a brokerage services provider. The company is based in London, UK. The British company was founded in 1999. Neil Robert Mackison has been the CEO of the company since 2006. | Investment Banks/Brokers | Corporate Officer/Principal | |
| Trisys Business Software Ltd. | Director/Board Member | ||
| IXICO PLC | Miscellaneous Commercial Services | Chairman Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| UK Medical Research Council | Corporate Officer/Principal | ||
| UCB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BTG | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chairman | |
Lonza Biologics Plc
 Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Biotec Laboratories Ltd.
 Biotec Laboratories Ltd. Medical SpecialtiesHealth Technology Part of Novacyt SAS, Biotec Laboratories Ltd. is a British company that produces and distributes diagnostic reagents, test kits and dehydrated culture media. The company is based in Ipswich, UK. Biotec Laboratories was acquired by Lab 21 Ltd. on March 03, 2009. | Medical Specialties | Director/Board Member | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Founder | |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of London | College/University | Doctorate Degree | |
| University of Birmingham | College/University | Undergraduate Degree Doctorate Degree | |
| Coventry University | College/University | Undergraduate Degree | |
| University of Sussex | College/University | Undergraduate Degree | |
| University of St. Andrews | College/University | Doctorate Degree | |
| University of Cardiff | College/University | Undergraduate Degree | |
Lab 21 Ltd.
 Lab 21 Ltd. Medical/Nursing ServicesHealth Services Lab 21 Ltd. operates as a healthcare diagnostics company. It specializes in providing patients, doctors, hospitals ,and healthcare providers with diagnostic information for disease identification, disease predisposition, and personalized medicine, to help in managing health problems. It also offers diagnostic products and services and supports blood bank screening, medical diagnostics, and drug discovery. The company was founded in April 2005 by Berwyn E. Clarke and is headquartered in Cambridge, the United Kingdom. | Medical/Nursing Services | Director of Finance/CFO | |
| University of Bedfordshire | College/University | Doctorate Degree | |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chairman Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| NOVACYT | Medical Specialties | Director of Finance/CFO | |
The Babraham Institute
 The Babraham Institute Miscellaneous Commercial ServicesCommercial Services Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB. | Miscellaneous Commercial Services | Chairman | |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Microgen Bioproducts Ltd.
 Microgen Bioproducts Ltd. Electronic Equipment/InstrumentsElectronic Technology Microgen Bioproducts Ltd. develops, manufactures, distributes, and markets clinical laboratory products. It offers biochemical identification and latex agglutination kits, path-check hygiene and pregnancy tests, pulsifier, and bacterial typing antisera. The company was founded in 1994 and is headquartered in Camberley, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom. | Investment Managers | Consultant / Advisor | |
Exonate Ltd.
 Exonate Ltd. Medical/Nursing ServicesHealth Services Exonate engages in the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. It develops SPHINXes, a pipeline of novel small molecule inhibitors. The company was founded by David Owen Bates, Lucy Donaldson, Steeven J. harper and Catherine Beech in 2013 and is headquartered in Nottingham, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Centauri Therapeutics Ltd.
 Centauri Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centauri Therapeutics Ltd. engages in manufacturing processing drugs in pharmaceutical preparations for life threatening diseases. The firm focuses on on the discovery and development of novel molecules targeting life threatening diseases. The company was founded by Mike Westby and Stuart Lawson and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Owlstone Medical Ltd.
 Owlstone Medical Ltd. Medical SpecialtiesHealth Technology Owlstone Medical Ltd. develops breathalyzer device for use in clinical diagnostics and precision medicine with applications in cancer, inflammatory and infectious disease. The firm offers Lonestar VOC Analyzer, ReCIVA Breath Sampler and ultraFAIMS products. It also offers consult, analyze, and discover, report and validation services. The company was founded by Paul Boyle and Alonso David Ruiz in 2004 and is headquartered in Cambridge, CA. | Medical Specialties | Director/Board Member | |
| BIVICTRIX THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| Babraham Research Campus | Director/Board Member | ||
Closed Loop Medicine Ltd.
 Closed Loop Medicine Ltd. Pharmaceuticals: MajorHealth Technology Closed Loop Medicine Ltd. operates as a new breed of therapeutics company focused on care pathways, outcomes and the provision of dynamic personalised regimens. It combines proven drugs with digital therapeutics enabling the digitisation and data capture of an entire care continuum. The company was founded by Felicity Sartain, Hakim Yadi, Paul Goldsmith, and David Cox in 2017 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| Scale-Up Institute | Director/Board Member | ||
| Bloomberg Intelligence | Corporate Officer/Principal | ||
| Alcheme Advisors | Founder | ||
| Formulation Science & Technology Group | Corporate Officer/Principal | ||
| The Academy of Pharmaceutical Sciences | Corporate Officer/Principal |
Statistiques
Internationale
| Royaume-Uni | 45 |
| Etats-Unis | 4 |
| Belgique | 2 |
| France | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 19 |
| Commercial Services | 8 |
| Consumer Services | 8 |
| Finance | 4 |
| Health Services | 4 |
Opérationnelle
| Director/Board Member | 57 |
| Corporate Officer/Principal | 29 |
| Chairman | 17 |
| Director of Finance/CFO | 17 |
| Independent Dir/Board Member | 12 |
Relations les plus connectées
| Insiders | |
|---|---|
| Andrew Richards | 44 |
| Christine Soden | 18 |
| Susan Lowther | 16 |
| Alan Smith | 10 |
| Jan Jezek | 8 |
| Mohammad Fazeli | 8 |
| Sarah Howell | 7 |
| Manjit Rahelu | 7 |
| Jeremy Morgan | 5 |
| David Gerring | 2 |
| Mo Noonan | 1 |
- Bourse
- Insiders
- Fiona Lawrence
- Connexions Sociétés
